Home/Filings/4/0001654954-22-001643
4//SEC Filing

Berk Gregory 4

Accession 0001654954-22-001643

CIK 0000109657other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:10 PM ET

Size

7.0 KB

Accession

0001654954-22-001643

Insider Transaction Report

Form 4
Period: 2021-02-16
Berk Gregory
Director
Transactions
  • Award

    Common Stock

    2021-02-16+278,058278,058 total
  • Award

    Option to purchase Common Stock

    2021-02-16+50,00050,000 total
    Exercise: $6.33Exp: 2031-02-15Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021.
  • [F2]Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023.

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1
  • filerCIK 0001306870

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:10 PM ET
Size
7.0 KB